Evernest Financial Advisors LLC Lowers Position in Danaher Corporation $DHR

Evernest Financial Advisors LLC reduced its stake in Danaher Corporation (NYSE:DHR) by 4.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,765 shares of the conglomerate’s stock after selling 197 shares during the quarter. Evernest Financial Advisors LLC’s holdings in Danaher were worth $941,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Turtle Creek Wealth Advisors LLC purchased a new stake in Danaher in the 2nd quarter valued at $328,000. Dash Acquisitions Inc. increased its position in shares of Danaher by 2.6% during the 2nd quarter. Dash Acquisitions Inc. now owns 81,185 shares of the conglomerate’s stock valued at $16,066,000 after purchasing an additional 2,070 shares during the last quarter. Generali Asset Management SPA SGR increased its position in shares of Danaher by 15.0% during the 2nd quarter. Generali Asset Management SPA SGR now owns 62,997 shares of the conglomerate’s stock valued at $12,444,000 after purchasing an additional 8,237 shares during the last quarter. Tuttle Capital Management LLC increased its position in shares of Danaher by 14.9% during the 2nd quarter. Tuttle Capital Management LLC now owns 2,679 shares of the conglomerate’s stock valued at $529,000 after purchasing an additional 348 shares during the last quarter. Finally, Ritholtz Wealth Management increased its position in shares of Danaher by 28.7% during the 2nd quarter. Ritholtz Wealth Management now owns 8,327 shares of the conglomerate’s stock valued at $1,645,000 after purchasing an additional 1,858 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on DHR. Guggenheim reaffirmed a “buy” rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Wells Fargo & Company decreased their target price on Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 target price on Danaher in a research report on Tuesday, September 2nd. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Finally, Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a report on Friday, July 11th. Seventeen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus target price of $244.60.

Danaher Stock Performance

Shares of DHR opened at $206.32 on Thursday. The company has a market cap of $147.73 billion, a PE ratio of 43.90, a price-to-earnings-growth ratio of 2.94 and a beta of 0.77. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a 50-day moving average price of $201.18 and a 200-day moving average price of $197.19. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.41.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter last year, the company posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.

Insider Activity

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.